Key facts
- It has raised $122.6M; the latest was Later Stage VC ($760K) in Jun 2024.
- Notable investors include Double Bioventures, ICP Group (Denmark), Innovation Fund America, Mitsubishi, Saudi Industrial Investment Group — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Unibio
- ·The full record, as it builds
Funding rounds
No funding rounds for Unibio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Unibio
Provider of a bioindustrial platform intended to produce sustainable protein at an industrial scale and address global food security challenges. The company offers a patented Vertical Loop Bioreactor that converts methane into protein through efficient, modular, and climate-independent fermentation, enabling food producers and agribusinesses to reduce environmental impact, conserve resources, and ensure a resilient and scalable food supply.
- Sector
- Healthcare
- HQ
- Roskilde, Denmark
- Founded
- 2001
- Employees
- 75
- Website
- unibio.dk/
- Ownership
- Privately Held (backing)
Unibio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Unibio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Unibio in its N-PORT filings yet. We sweep new filings monthly.